Press Releases

12345678910
Intelligence Redefining Luxury: AITO Full Lineup Debuts at Auto China 2026
On April 24, AITO’s full product range and SERES’ latest technological achievements were unveiled at Auto China 2026 — the AITO M6 made its powerful debut, the all-new AITO M9 was revealed for the first time, the AITO M8, M7, and M5 were displayed together, and the MF Platform was innovatively launched.
Via Get News · April 27, 2026
BABCOCK & WILCOX CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Urges Babcock & Wilcox Enterprises, Inc. Investors with Large Losses to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In B&W (BW) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · April 27, 2026
Media from Nine Countries Gear Up for OMODA & JAECOO Super Hybrid Marathon
Leading media representatives from nine countries—France, Poland, Spain, Saudi Arabia, Vietnam, Australia, South Africa, Pakistan, and Brazil—are set to gather in China for the OMODA & JAECOO "9 Countries Super Hybrid Marathon", an extreme long-distance test drive event. They will experience the OMODA 5, JAECOO 5, and JAECOO 7 HEV models, all powered by the world-leading SHS (Super Hybrid System). This long-range test is anchored by three core pillars. Hardcore real-world testing across diverse road conditions sets the tone. An immersive, aesthetic journey through natural landscapes adds the soul of youthful spirit. A ceremonial finale with official honours will leave its mark on the entire journey. This comprehensive hybrid experience spanning mountains and seas is about to unfold.
Via Get News · April 27, 2026
Ed Morse Automotive Group Acquires Chrysler Jeep Ram Dealership in Lebanon, Missouri
The Ed Morse Automotive Group announced today it has acquired Graven Chrysler Jeep Ram in Lebanon, Missouri. Located at 1755 W. Elm Street in Lebanon, the new name of the dealership will be Ed Morse Chrysler Dodge Jeep Ram.
By Ed Morse Automotive Group · Via Business Wire · April 27, 2026
Erica Jackson Unveils The Awakening of the Spirit on Amazon, Igniting a Message of Faith, Courage, and Purpose
United States - April 27, 2026 - Author Erica Jackson announces the release of her transformative book, The Awakening of the Spirit, now available on Amazon, marking a powerful moment in a journey defined by faith, resilience, and the courage to move forward without certainty. Alongside this milestone, Jackson is participating in the Hollywood International Impact Book Awards – Author of the Year 2026 Competition and the Entrepreneur of Impact Competition , expanding the reach of a message rooted in purpose and service.
Via Get News · April 27, 2026
Rhode Island Lawyer Represents Victims’ Families in Pawtucket Hockey Game Shooting
Lawrence J. Signore is pleased to announce that he has been retained to represent family members of victims killed or injured in the mass shooting that occurred during a high school hockey game. The Rhode Island lawyer has more than 20 years of experience, with practice areas including personal injury and workers’ compensation.
Via Get News · April 27, 2026
Tidewater Announces Earnings Release and Conference Call
Tidewater Inc. (NYSE: TDW) (“Tidewater” or the “Company”) announced today that it will release financial results for the three months ending March 31, 2026, on Monday, May 4, 2026 after market close. An earnings conference call has been scheduled for Tuesday, May 5, 2026, at 8:00 a.m. Central Time, during which President and Chief Executive Officer Quintin Kneen will discuss results for the three months ending March 31, 2026.
By Tidewater Inc. · Via Business Wire · April 27, 2026
Doherty Enterprises Honors Three Long Island Educators in 10th Annual Above and ‘BEE’yond Teacher Essay Contest
LONG ISLAND, N.Y., April 27, 2026 (SEND2PRESS NEWSWIRE) -- Doherty Enterprises-owned Applebee's® Neighborhood Grill & Bar restaurants on Long Island are proud to announce the winners of the 10th annual Above and 'BEE'yond Teacher Essay Contest, recognizing outstanding educators nominated by their students.
Via Send2Press · April 27, 2026
Jaystone Renovation & Interior Design Singapore Launches Platform to Simplify Renovation and Interior Design for Homeowners in Singapore
Jaystone Renovation Contractor Singapore has officially rebranded as Jaystone Renovation & Interior Design Singapore, marking its transformation from a traditional renovation contractor into a platform that helps homeowners navigate renovation and interior design in Singapore with clarity and confidence.
Via Get News · April 27, 2026
Auckland Contracting Sector Sees Rise in Integrated Waterproofing and Tiling Services
As building regulations become more stringent, the local residential and commercial construction sector continues to demand higher standards of technical execution. In its effort to comply with the New Zealand Building Code, Dakom Tiling is streamlining its operations to provide integrated waterproofing and tiling services Auckland .
Via Get News · April 27, 2026
A “Mountain-and-Sea Pact” Spanning 4,000 Kilometers – Highlights from Xingcheng City Promotion Event in Sanya
In April, Sanya is bathed in gentle sea breezes and swaying palm trees. On the beach at Dadonghai Scenic Area, performers dressed in traditional Chinese attire transformed into “promotion ambassadors,” inviting tourists to interact and creating a striking scene along the shoreline. This was not a local folk event, but a promotional showcase from over 3,000 kilometers away—Xingcheng.
Via Get News · April 27, 2026
Crypto News Today: Pepeto CoinMarketCap Listing Goes Live While BNB Price Prediction Points Toward $2,000
Crypto news today centers on Pepeto after the project put up a token page on CoinMarketCap, and the presale pushed
Via First Publisher · April 27, 2026
The Boxery expands mailer box options for consistent unboxing experiences
LYNDHURST, N.J. - The Boxery announced a branded packaging assortment centered on mailer boxes, envelopes, and presentation-ready shipping supplies for direct-to-consumer (DTC) businesses, giving smaller brands a way to create a more consistent unboxing experience without moving into fully custom packaging. The launch is aimed at online sellers who want packaging consistency, better presentation, and operational efficiency while maintaining flexible order quantities.
Via Get News · April 27, 2026
FirstSun Capital Bancorp Reports First Quarter 2026 Results
FirstSun Capital Bancorp (“FirstSun”) (NASDAQ: FSUN) reported net income of $21.6 million for the first quarter of 2026 compared to net income of $23.6 million for the first quarter of 2025. Earnings per diluted share were $0.76 for the first quarter of 2026 compared to $0.83 for the first quarter of 2025. Adjusted net income, a non-GAAP financial measure, was $23.7 million or $0.84 per diluted share for the first quarter of 2026.
By FirstSun Capital Bancorp · Via Business Wire · April 27, 2026
Studycat expands pronunciation support for early learners in kids spanish language apps
Studycat, the Hong Kong-based company behind child-focused language learning products, will announce an update to its speech-practice experience in kids' Spanish language apps, with a focus on clearer pronunciation feedback for children learning their first Spanish words and phrases. The update is designed to support early learners through guided speaking practice while reinforcing Studycat's privacy-conscious, ad-free approach to language learning.
Via Get News · April 27, 2026
EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of SES AI Corporation Investors – SES
Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of SES AI Corporation (NYSE: SES) between January 29, 2025 and March 4, 2026, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for SES AI Corporation investors under the federal securities laws.
By Rosen Law Firm · Via Business Wire · April 27, 2026
Hummingbird.org Highlights Growing Importance of LinkedIn Network-Building Following 1,000+ Attendee Webinar
Denver, CO - April 27, 2026 - Hummingbird.org for advisors, also known as Hummingbird Growth & Automation, is highlighting the increasing importance of intentional LinkedIn network-building as a modern business growth strategy, following a recent company-hosted webinar that attracted more than 1,000 attendees.
Via Get News · April 27, 2026
Central Garden & Pet to Announce Q2 Fiscal 2026 Financial Results
Central Garden & Pet Company (NASDAQ: CENT) (NASDAQ: CENTA) (“Central”), a leading consumer goods company in the pet and garden industries, will release its fiscal 2026 second quarter results for the period ending March 28, 2026, after market close on Wednesday, May 6, 2026. On the same day, Central will host a conference call at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time), led by CEO Niko Lahanas and CFO Brad Smith, to review these results and to provide a business update.
By Central Garden & Pet Company · Via Business Wire · April 27, 2026
PACS Group, Inc. Announces the Appointment of Carey P. Hendrickson as Chief Financial Officer
PACS Group, Inc. (NYSE: PACS), one of the nation’s largest and fastest-growing post-acute healthcare platforms, today announced the appointment of Carey P. Hendrickson as its Chief Financial Officer, effective April 27, 2026. Mr. Hendrickson brings to PACS nearly four decades of financial leadership spanning public company CFO roles in healthcare, senior living, and media — a body of work distinguished by financial discipline, strategic acuity, and a consistent record of building high-performing teams that drive measurable results. His appointment marks a significant milestone for PACS as the company continues to scale its national footprint and deepen its clinical and operational leadership in the post-acute sector.
By PACS Group, Inc. · Via Business Wire · April 27, 2026
Dyne Therapeutics Announces Upcoming Presentation Highlighting Robust CNS Activity in Nonhuman Primates with its FORCE™ Platform at 2026 ASGCT Annual Meeting
- Data underscore the differentiated capability of the clinically validated FORCE platform to cross the blood-brain barrier -
By Dyne Therapeutics, Inc. · Via GlobeNewswire · April 27, 2026
A Groundbreaking Retirement Guide – Rob Burnette’s Newly Released Book Turns Retirement Planning into a Complete System
Lexington, Kentucky, USA - April 27, 2026 - Renowned financial planner and investment expert Rob Burnette has released his book, The Retirement Periscope: How a Clear Financial Perspective Leads to Better Preparation and Disciplined Decision-Making . This vital resource serves as a guide for American families to approach retirement with confidence and understanding. It provides a structured yet adaptable financial framework to help individuals make well-informed, long-term decisions.
Via Get News · April 27, 2026
Babcock & Wilcox Sets First Quarter 2026 Conference Call and Webcast for Monday, May 11, 2026 at 5 p.m. ET
Babcock & Wilcox Enterprises, Inc. (NYSE:BW) (B&W or the “Company”) will host a conference call and webcast on Monday, May 11, 2026 at 5 p.m. ET.
Onterris Announces Timing of First Quarter 2026 Results
Onterris, Inc. (NYSE: Montrose Environmental Group, Inc., MEG; changing to NYSE: Onterris, Inc., ONT on May 4, 2026), a global environmental solutions company solving complex challenges for planet and progress, today announced the planned dates for its first quarter fiscal year 2026 results and conference call.
PACS Group, Inc. Announces Retirement of Co-Founder and CFO Mark Hancock
PACS Group, Inc. (NYSE: PACS), one of the nation’s largest and fastest-growing post-acute healthcare platforms, today announced the planned retirement of Mark Hancock — PACS co-founder, first CFO, and one of the principal architects behind the company’s success — on June 30, 2026.
By PACS Group, Inc. · Via Business Wire · April 27, 2026
Johnson & Johnson to Participate in the Bernstein’s 42nd Annual Strategic Decisions Conference
Johnson & Johnson (NYSE: JNJ) will present at the Bernstein’s 42nd Annual Strategic Decisions Conference on Wednesday, May 27th, 2026. Management will participate in a Fireside Chat at 11:00 a.m. Eastern Time.
By Johnson & Johnson · Via Business Wire · April 27, 2026
Nanjing Hosts 16th China Traffic Safety Expo Focused on Smart & Safe Mobility
Nanjing, China - The 16th China International Road Traffic Safety Products Expo was successfully held in Nanjing on April 22. Centered on the theme of “New Quality Drivers for Transportation, Forging Safety with Four New Priorities”, the influential industry event covers an exhibition area of 40,000 square meters with three major themed pavilions and more than 1,800 booths. It has attracted over 360 participating institutions and enterprises, showcasing nearly 4,000 exhibits featuring cutting-edge smart transportation innovations. The displayed highlights range from full-domain road network digital intelligent collaborative platforms and AI traffic control intelligent agents to radar-video integrated holographic perception equipment and air-ground integrated intelligent inspection solutions, fully presenting how core technologies including artificial intelligence and big data empower modern refined traffic management.
Via Get News · April 27, 2026
Eight Student Teams Named National Winners of 34th Annual ExploraVision Competition
Toshiba and the National Science Teaching Association (NSTA) today announce eight national winners of the 34th annual Toshiba/NSTA ExploraVision competition, the world’s largest K-12 science competition. This year’s winners have shared innovative proposals to help overcome some of the greatest challenges facing the world today, from healthcare challenges to transportation efforts to protecting the environment.
By Toshiba · Via Business Wire · April 27, 2026
Editas Medicine to Present New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at Upcoming Scientific Conferences
CAMBRIDGE, Mass., April 27, 2026 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that five abstracts have been accepted for presentation, including one oral presentation and two poster presentations at the American Society of Gene and Cell Therapy (ASGCT) 2026 Annual Meeting, one oral presentation at TIDES USA 2026: Oligonucleotide and Peptide Therapeutics Conference, and one oral presentation at the 94th European Atherosclerosis Society (EAS) Congress. The Company is presenting new preclinical data, including data to support the potential of EDIT-401, its lead in vivo development candidate, to be a transformative therapy for people living with hyperlipidemia.
By Editas Medicine, Inc. · Via GlobeNewswire · April 27, 2026
The Tampa Roofer LLC Strengthens Position as a Trusted Roofing Provider in Tampa
With a focus on durability and long-term performance, The Tampa Roofer LLC offers a wide range of services including roof installation, repair, maintenance, and replacement. Each project is handled with precision using industry-leading materials and proven techniques designed to withstand Florida’s challenging weather conditions.
Via Get News · April 27, 2026
Phibro Animal Health Corporation Announces Regulatory Framework Change in Brazil for Antimicrobials
Phibro Animal Health Corporation (Nasdaq: PAHC) today announced expected implementation of a new regulatory framework governing the use of certain antimicrobials in Brazil that have growth promotion indications.
Lifezone Announces Release Date of Q1 2026 Interim Financial Results and Notice of Investor Webcast
Lifezone Metals Limited (NYSE: LZM) announced today that it plans to release its Q1 2026 interim financial results on April 30, 2026.
By Lifezone Metals · Via Business Wire · April 27, 2026
InTest Schedules First Quarter 2026 Financial Results Conference Call and Webcast
InTest Corporation (NYSE American: INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets which include semiconductor (“semi”), automotive/EV, defense/aerospace, industrial, life sciences and safety/security, announced it will release its first quarter 2026 financial results before the opening of financial markets on Tuesday, May 5, 2026.
By InTest Corporation · Via Business Wire · April 27, 2026
Strand Therapeutics to Present Preclinical Data on Its Programmable mRNA In Vivo CAR-T Platform at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Strand Therapeutics, a clinical-stage biotechnology company pioneering programmable mRNA medicines, today announced it will present preclinical data from its in vivo CAR-T program at the 2026 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting, taking place May 11-15 in Boston.
By Strand Therapeutics · Via Business Wire · April 27, 2026
Rithm Capital’s Paramount Group Rebrands as Elecor Properties, a Premier Real Assets Platform Built for the Future of the Workplace
Rithm Capital Corp. (NYSE: RITM) ("Rithm"), a global alternative asset manager, today announced that its commercial real estate platform Paramount Group, has officially rebranded as Elecor Properties ("Elecor"), a premier real estate platform redefining the modern workplace. The new identity reflects a strategic transformation from a high quality, Class A office portfolio into an operating platform built for the next evolution of the workplace.
By Elecor Properties · Via Business Wire · April 27, 2026
SmartRent Launches Value-Added Reseller Program
SmartRent, Inc. (NYSE: SMRT) (“SmartRent” or the “Company”), a leading provider of smart communities and smart operations solutions for the rental housing industry, today announced the launch of its strategic value-added reseller (VAR) program. This initiative marks an expansion of SmartRent’s go-to-market model and is designed to address the needs of small and mid-market rental housing owners and operators. SKBM Smart Technology, a long-time SmartRent installation provider, will be the first VAR in the program.
By SmartRent · Via Business Wire · April 27, 2026
Dyno Therapeutics to Present New Capsids and AI Advancements in Gene Delivery at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to solve the grand challenge of in vivo gene delivery, today announced that it will host a Scientific Symposium, present a talk at the invitation of the Viral Gene Transfer Vectors Committee, and present four research abstracts at the 29th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT), taking place May 11-15, 2026 in Boston, Massachusetts.
By Dyno Therapeutics, Inc. · Via Business Wire · April 27, 2026
Encoded Therapeutics to Present ETX101 Data in Dravet Syndrome at the 2026 ASGCT Presidential Symposium
Encoded Therapeutics Inc., a clinical-stage genetic medicines company, today announced its participation in the 29th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT), taking place May 11–15, 2026, in Boston, Massachusetts. Encoded will present three abstracts, including one oral presentation in the Presidential Symposium and two scientific posters, demonstrating the breadth of its vector engineering platform across severe neurological disorders.
By Encoded Therapeutics, Inc. · Via Business Wire · April 27, 2026
Mirai Bio to Unveil Two Next Generation Programs for Targeted Nucleic Acid Delivery Beyond the Liver at ASGCT 2026
Mirai Bio, the innovation delivery partner for companies developing next generation nucleic acid medicines, today announced that it will present three abstracts at ASGCT 2026, including one oral presentation and two posters highlighting progress in two different targeted lipid nanoparticle delivery programs. Together, the presentations highlight both the rising bar for nucleic acid medicine delivery beyond the liver and how Mirai’s extensive proprietary, in vivo biodistribution data-powered machine learning approach enables best-in-class LNP design, improves selectivity and tolerability, and ensures functional performance in vivo across programs.
By Mirai Bio · Via Business Wire · April 27, 2026
Ellington Financial Announces Estimated Book Value Per Common Share as of March 31, 2026
Ellington Financial Inc. (NYSE: EFC) ("we") today announced an estimated book value per share of common stock of $13.56 as of March 31, 2026. This estimate includes the effect of the previously announced monthly dividend of $0.13 per share of common stock, to be paid on April 30, 2026 to holders of record on March 31, 2026, with the same ex-dividend date.
By Ellington Financial Inc. · Via Business Wire · April 27, 2026
Sail Biomedicines to Present Preclinical Data Supporting Advancement of Its In Vivo eRNA™ CAR-T Product Candidate to the Clinic at ASGCT 2026 and TIDES USA 2026
Sail Biomedicines, a Flagship Pioneering company and leader in RNA-based programmable medicines, today announced that it will present preclinical updates from its vanguard In Vivo eRNA and targeted nanoparticle (TNP) CAR-T program and lead product candidate for autoimmune diseases at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting and TIDES USA 2026, taking place in Boston.
By Sail Biomedicines · Via Business Wire · April 27, 2026
Dispatch Bio Presents SEND T Cell Armoring Strategy at ASGCT 2026 Annual Meeting
Dispatch Bio, a biotech company engineering a universal treatment across solid tumors leveraging its first-in-class Flare platform, today announced the presentation of new preclinical data supporting its SEND (Synthetic Efficacy eNableD) T cell armoring strategy at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting, taking place May 11–15, 2026, in Boston. The data will be presented in a poster entitled, “SEND – A T cell armoring strategy that incorporates simultaneous signaling through multiple pathways for optimized safety and efficacy via novel cell state,” during a poster session on Thursday, May 14, from 5:00–6:30 p.m.
By Dispatch Bio · Via Business Wire · April 27, 2026
Travere Therapeutics to Report First Quarter 2026 Financial Results
Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced it will report first quarter 2026 financial results on Monday, May 4, 2026, after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET.
By Travere Therapeutics, Inc. · Via Business Wire · April 27, 2026
Tr1X to Present New Clinical and Preclinical Data on Engineered Tr1 Treg Cell Therapies at ASGCT 2026
Tr1X, Inc., a clinical-stage autoimmune and inflammatory disease company developing Type 1 regulatory T (Tr1) cell therapies, today announced two oral presentations at the American Society of Gene and Cell Therapy Annual Meeting 2026, May 11-15, 2026, in Boston.
By Tr1X, Inc. · Via Business Wire · April 27, 2026
Matador Resources Company Announces Leadership Promotions
Matador Resources Company (NYSE: MTDR) (“Matador”) today announced the following promotions, effective as of April 21, 2026:
By Matador Resources Company · Via Business Wire · April 27, 2026
AviadoBio Announces Agreement with Apertura Gene Therapy to License TfR1 CapX™, a Next-Generation Blood-Brain Barrier-Crossing Capsid
AviadoBio Ltd. (“AviadoBio”) and Apertura Gene Therapy (“Apertura”), a biotechnology company developing next-generation AAV capsids for delivering genetic medicines, today announced a licensing agreement for Apertura’s TfR1 CapX™, a novel, intravenously-delivered AAV capsid designed to target human transferrin receptor 1 (hTfR1), cross the blood-brain barrier, and enable broad distribution to the brain and spinal cord.
By AviadoBio Ltd. · Via Business Wire · April 27, 2026
Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting
SEATTLE, April 27, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that an abstract highlighting preclinical data from SG293, its CD19-directed in vivo CAR T product candidate, has been accepted for oral presentation at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting taking place May 11-15, 2026 in Boston, MA.
By Sana Biotechnology, Inc · Via GlobeNewswire · April 27, 2026
TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 29th Annual Meeting
WALTHAM, Mass., April 27, 2026 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with cancer, today announced the acceptance of an abstract for poster presentation at the upcoming American Society of Gene and Cell Therapy (ASGCT) 29ᵗʰ Annual Meeting being held May 11 – 15 in Boston, MA as well as virtually.
By TScan Therapeutics, Inc. · Via GlobeNewswire · April 27, 2026
Robin Energy Announces Final Results of Tender Offer for Common Shares
LIMASSOL, Cyprus, April 27, 2026 (GLOBE NEWSWIRE) -- Robin Energy Ltd. (NASDAQ: RBNE) (“Robin Energy” or the “Company”), an international ship-owning company providing energy transportation services globally, announces today the final results of its tender offer (the “Offer”), which expired at 5:00 P.M. Eastern time on April 23, 2026.
By Robin Energy Ltd. · Via GlobeNewswire · April 27, 2026
Charlton Aria Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination
Wilmington, DE, April 27, 2026 (GLOBE NEWSWIRE) -- Charlton Aria Acquisition Corporation (Nasdaq: CHARU), a Cayman Islands exempted company (the “Company”) today announced that on April 24, 2026, ST Sponsor II Limited (the “Sponsor”) of the Company deposited $850,000 into the trust account, as a result of which, the Company has until July 25, 2026 to complete its initial business combination (the “Extension”).
By Charlton Aria Acquisition Corp · Via GlobeNewswire · April 27, 2026
Cellectis Presents Epigenetic Editing Platform to Turn Genes Off Without Altering DNA at the ASGCT Annual Meeting
NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving cell and gene therapies, today presents new research on a TALE-based epigenetic editing approach, that does not cut or permanently modify the DNA sequence, making it a potentially safer alternative for genome editing, at the American Society of Gene and Cell Therapy (ASGCT) annual meeting, that will be held on May 11-15, in Boston (MA).
By Cellectis Inc. · Via GlobeNewswire · April 27, 2026